Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ras signaling pathway is a central cellular signaling cascade that regulates cell proliferation, survival, differentiation, apoptosis, cytoskeletal dynamics, and gene expression. It is activated by growth factors and other extracellular signals leading to GTP-binding and activation of Ras proteins (KRAS, NRAS, HRAS). Activated Ras then triggers downstream pathways such as MAPK/ERK, PI3K/AKT/mTOR, and others. Dysregulation of this pathway, often due to mutations in Ras genes, is implicated in cancer and developmental disorders. Therapies targeting components of this pathway are used in cancer treatment, but resistance and safety concerns remain significant challenges.
Inhibition of downstream kinases (MEK, RAF, PI3K, mTOR) or direct inhibition of mutated Ras proteins (e.g., KRAS G12C inhibitors)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras Signaling Pathway (Activated) (Ras Pathway (Activated)).